title: The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
abstract: The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP spikes and its impact on glaucoma practice.
  Skalicky SE, I Clement C. The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services? J Current Glau Prac 2012;6(2):55-57.
authors.affiliation: Sydney Eye Hospital, Sydney, Australia.
authors.forename: Simon E
authors.initials: SE
authors.lastname: Skalicky
authors.affiliation: Department of Glaucoma Unit, Sydney Eye Hospital, NSW, Australia.
authors.forename: Colin I
authors.initials: CI
authors.lastname: Clement
keywords: Bevacizumab; Glaucoma; VEGF.